Deltasone: Potent Systemic Corticosteroid for Inflammation Control

Deltasone

Deltasone

Price from 40.42 $
Product dosage: 10mg
Package (num)Per pillPriceBuy
60$0.67$40.42 (0%)🛒 Add to cart
90$0.55$60.63 $49.88 (18%)🛒 Add to cart
120$0.50$80.84 $60.20 (26%)🛒 Add to cart
180$0.44$121.26 $79.98 (34%)🛒 Add to cart
270$0.41$181.89 $110.94 (39%)🛒 Add to cart
360
$0.39 Best per pill
$242.52 $141.04 (42%)🛒 Add to cart
Product dosage: 20mg
Package (num)Per pillPriceBuy
60$0.79$47.30 (0%)🛒 Add to cart
90$0.73$70.95 $65.36 (8%)🛒 Add to cart
120$0.70$94.60 $83.42 (12%)🛒 Add to cart
180$0.65$141.90 $117.82 (17%)🛒 Add to cart
270$0.64$212.85 $172.86 (19%)🛒 Add to cart
360
$0.62 Best per pill
$283.80 $223.60 (21%)🛒 Add to cart
Product dosage: 40mg
Package (num)Per pillPriceBuy
60$0.89$53.32 (0%)🛒 Add to cart
90$0.81$79.98 $73.10 (9%)🛒 Add to cart
120$0.77$106.64 $92.88 (13%)🛒 Add to cart
180$0.74$159.96 $133.30 (17%)🛒 Add to cart
270$0.72$239.94 $195.22 (19%)🛒 Add to cart
360
$0.71 Best per pill
$319.92 $254.56 (20%)🛒 Add to cart
Product dosage: 5mg
Package (num)Per pillPriceBuy
180$0.28$50.74 (0%)🛒 Add to cart
270$0.26$76.11 $69.66 (8%)🛒 Add to cart
360
$0.25 Best per pill
$101.48 $89.44 (12%)🛒 Add to cart
Synonyms

Deltasone is the brand name for the systemic corticosteroid medication prednisone, a cornerstone in the management of a wide spectrum of inflammatory and autoimmune conditions. It functions as a potent anti-inflammatory and immunosuppressive agent, mimicking the effects of hormones naturally produced by the adrenal glands. By systematically modulating the body’s immune response, Deltasone provides rapid and effective relief from debilitating symptoms, helping to restore function and improve quality of life for patients under expert medical supervision. Its use is a critical component of treatment protocols in rheumatology, dermatology, pulmonology, hematology, and transplant medicine.

Features

  • Active Ingredient: Prednisone (5mg, 10mg, 20mg, 50mg scored tablets).
  • Drug Class: Synthetic glucocorticoid (corticosteroid).
  • Administration: Oral tablet.
  • Mechanism of Action: Binds to intracellular glucocorticoid receptors, modulating gene expression to inhibit pro-inflammatory cytokine production, decrease eosinophil action, and impair lymphocyte function.
  • Bioavailability: High oral bioavailability, with peak plasma concentrations reached within 1 to 2 hours.
  • Metabolism: Hepatically metabolized via CYP3A4 isoenzyme to its active form, prednisolone.
  • Excretion: Primarily renal excretion of metabolites.

Benefits

  • Rapid Symptom Control: Provides swift and powerful suppression of inflammatory processes, leading to a noticeable reduction in pain, swelling, redness, and other hypersensitivity reactions.
  • Disease Remission Induction: Effectively induces remission in acute exacerbations of chronic autoimmune diseases, preventing long-term tissue damage and organ dysfunction.
  • Immunosuppressive Action: Calms an overactive immune system, making it indispensable for preventing organ transplant rejection and managing autoimmune disorders.
  • Improved Functional Capacity: By alleviating inflammation, it restores mobility, respiratory function, and overall daily living activities for patients.
  • Dosing Flexibility: Available in multiple strengths and as a scored tablet, allowing for precise titration and customized tapering schedules tailored to individual patient needs and specific conditions.

Common use

Deltasone (prednisone) is indicated for a broad range of conditions where suppression of inflammation or the immune system is therapeutic. Its common uses include, but are not limited to:

  • Rheumatologic Disorders: Severe active rheumatoid arthritis, systemic lupus erythematosus (SLE), polymyalgia rheumatica, giant cell arteritis, and acute gouty arthritis.
  • Allergic Conditions: Severe or incapacitating allergic conditions unresponsive to conventional treatment, severe seasonal or perennial allergic rhinitis, and contact dermatitis.
  • Dermatologic Diseases: Pemphigus vulgaris, severe psoriasis, exfoliative dermatitis, and severe seborrheic dermatitis.
  • Ophthalmic Diseases: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa.
  • Respiratory Diseases: Symptomatic sarcoidosis, idiopathic eosinophilic pneumonias, and as part of management for severe asthma and COPD exacerbations.
  • Hematologic Disorders: Idiopathic thrombocytopenic purpura (ITP), autoimmune hemolytic anemia, and acquired (autoimmune) hemolytic anemia.
  • Neoplastic Diseases: Palliative management of leukemias and lymphomas in adults and acute leukemia in children.
  • Edematous States: To induce a diuresis or remission of proteinuria in nephrotic syndrome.
  • Gastrointestinal Diseases: To tide patients over a critical period of disease in ulcerative colitis and Crohn’s disease.
  • Nervous System: Acute exacerbations of multiple sclerosis.
  • Endocrine Disorders: As replacement therapy for primary or secondary adrenal insufficiency (cortisol deficiency).

Dosage and direction

Crucial: Dosage must be individualized based on the specific disease, its severity, and the patient’s response. The following is general guidance; always adhere to the precise regimen prescribed by the treating physician.

  • Initial Dosage: May range from 5 mg to 60 mg of prednisone per day, depending on the disease entity being treated. More severe diseases often require higher initial doses.
  • Administration: Should be taken with food or milk to minimize gastrointestinal upset. A single daily dose is typically administered in the morning to coincide with the body’s natural circadian rhythm of cortisol secretion, which may reduce the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression and insomnia.
  • Tapering (Discontinuation): ABSOLUTELY CRITICAL. Long-term therapy must never be discontinued abruptly. Dosage must be decreased gradually (tapered) under medical supervision. The rate of tapering is based on the dose, duration of therapy, the underlying disease, and individual patient tolerance. Abrupt withdrawal can lead to adrenal insufficiency, disease flare-up, and other withdrawal symptoms.
  • Stress Dosing: Patients on long-term therapy may require increased dosage before, during, and after periods of significant physiological stress (e.g., surgery, infection, trauma).

Precautions

  • Medical Supervision: This drug requires close supervision by a physician experienced in immunosuppressive therapy. Routine monitoring is essential.
  • Infections: Corticosteroids like Deltasone mask signs of infection and may enhance the spread of existing infections. Any perceived infection (fever, sore throat) must be reported immediately. Latent diseases such as tuberculosis may be reactivated.
  • Vaccinations: Administration of live or live-attenuated vaccines is contraindicated. Killed or inactivated vaccines may be administered, but the response may be diminished.
  • HPA Axis Suppression: Prolonged therapy can lead to suppression of the adrenal glands’ ability to produce natural cortisol. This is the primary reason for mandatory tapering.
  • Ophthalmic Exams: Prolonged use may cause posterior subcapsular cataracts, glaucoma with possible damage to the optic nerves and may enhance the establishment of secondary ocular infections due to fungi or viruses.
  • Cardiovascular/Renal: Use with caution in patients with hypertension, congestive heart failure, or renal insufficiency due to potential fluid and electrolyte disturbances (sodium retention, potassium loss, hypokalemic alkalosis).
  • GI Effects: Increased risk of peptic ulceration, including gastric and duodenal ulcers, with potential for perforation and hemorrhage. Use with caution in patients with existing GI disorders.
  • Musculoskeletal: Prolonged use can lead to osteoporosis, vertebral compression fractures, aseptic necrosis of femoral and humeral heads, and muscle weakness (steroid myopathy).
  • Behavioral Effects: May cause severe psychological disturbances, including euphoria, insomnia, mood swings, personality changes, severe depression, and frank psychotic manifestations.

Contraindications

Deltasone is contraindicated in patients with:

  • Systemic Fungal Infections: Unless used as life-saving therapy in conjunction with appropriate antifungal treatment.
  • Known Hypersensitivity: To prednisone or any component of the formulation.
  • Cerebral Malaria: As it has been associated with increased mortality.
  • Concurrent Administration of Live Vaccines.
  • Idiopathic Thrombocytopenic Purpura (ITP), when administered intramuscularly.

Possible side effect

Side effects are dose and duration-dependent. Possible adverse reactions include:

  • Fluid and Electrolyte: Fluid retention, sodium retention, potassium loss, hypokalemic alkalosis, hypertension.
  • Musculoskeletal: Muscle weakness, steroid myopathy, loss of muscle mass, osteoporosis, vertebral compression fractures, aseptic necrosis of bone, tendon rupture.
  • Gastrointestinal: Peptic ulcer with possible perforation and hemorrhage, pancreatitis, abdominal distention, ulcerative esophagitis.
  • Dermatologic: Impaired wound healing, thin fragile skin, petechiae and ecchymoses, facial erythema.
  • Neurological/Psychiatric: Convulsions, increased intracranial pressure with papilledema, vertigo, headache, severe psychological disturbances.
  • Endocrine: Menstrual irregularities, development of cushingoid state, HPA axis suppression, growth suppression in children.
  • Ophthalmic: Glaucoma, exophthalmos, cataracts.
  • Metabolic: Negative nitrogen balance due to protein catabolism, hyperglycemia.
  • Other: Increased appetite, weight gain, malaise.

Drug interaction

Deltasone has the potential to interact with numerous medications. Inform your physician of all drugs you are taking, including:

  • Anticoagulants (e.g., Warfarin): Altered response; requires close monitoring of INR.
  • Antidiabetic Agents (Insulin, Oral Hypoglycemics): May increase blood glucose, necessitating dosage adjustment of antidiabetic drugs.
  • CYP3A4 Inducers (e.g., Phenobarbital, Phenytoin, Rifampin): May increase the clearance of prednisone, reducing its efficacy.
  • CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole): May decrease the clearance of prednisone, increasing the risk of toxicity.
  • Diuretics (especially Potassium-Depleting, e.g., Furosemide, Thiazides): May enhance electrolyte depletion, particularly hypokalemia.
  • NSAIDs (e.g., Ibuprofen, Naproxen): Concomitant use increases the risk of GI ulceration and bleeding.
  • Live Vaccines: Concomitant use is contraindicated.
  • Cardiac Glycosides (e.g., Digoxin): Hypokalemia may increase the risk of digitalis toxicity.

Missed dose

  • If you miss a dose, take it as soon as you remember.
  • However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
  • Do not double the dose to catch up.
  • If you are on a tapered schedule, contact your physician for guidance, as this can disrupt the carefully planned regimen.

Overdose

  • Acute overdosage is unlikely to cause acute life-threatening problems. It would be expected to produce effects that are an extension of its pharmacological activity and adverse reactions (e.g., hyperglycemia, fluid retention, hypertension).
  • There is no specific antidote.
  • Treatment is supportive and symptomatic. Management includes gastric lavage or emesis followed by supportive and symptomatic therapy.
  • In the event of an overdose, seek immediate medical attention or contact a Poison Control Center.

Storage

  • Store at room temperature between 20°C to 25°C (68°F to 77°F).
  • Protect from light and moisture.
  • Keep in the original container, tightly closed.
  • Keep out of reach of children and pets.
  • Do not flush medications down the toilet or pour them into a drain unless instructed to do so.

Disclaimer

This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content has been compiled from various resources but may not be exhaustive or fully updated. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.

Reviews

  • “As a rheumatologist, Deltasone is an indispensable tool for managing acute flares in my autoimmune patients. The rapid onset of action is critical for controlling inflammation and preventing joint damage. The key, of course, is meticulous management of the tapering protocol.” – Dr. A. Reynolds, MD, Rheumatology
  • “After my kidney transplant, Deltasone was part of my immunosuppressive cocktail. While the side effects were challenging (moon face, weight gain), it was a necessary component to prevent rejection. My care team was excellent at managing the dosage.” – Patient M.K.
  • “For severe asthma exacerbations, a short course of high-dose Deltasone can be life-changing, rapidly reducing airway inflammation and avoiding hospitalization. We always emphasize the short-term nature of such bursts to patients to ensure compliance and alleviate concerns about long-term effects.” – Dr. L. Chen, Pulmonologist
  • “Managing my daughter’s nephrotic syndrome has been a long road. Deltasone successfully induces remission every time she has a relapse. The behavioral side effects are difficult, but we work closely with her nephrologist to find the lowest effective dose and taper as quickly as possible.” – Parent of a patient